openPR Logo
Press release

The COVID-19 Fallout: What to Expect from Therapeutic Obstructive Sleep Apnea Devices Industry in 2020?

05-13-2020 06:37 AM CET | Health & Medicine

Press release from: Research Dive

Therapeutic Obstructive Sleep Apnea Devices

Therapeutic Obstructive Sleep Apnea Devices

Post COVID-19 Impact on Therapeutic Obstructive Sleep Apnea Devices Market -

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues.

Research Dive' group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following:
o Long-term and short-term impact of Covid-19 on the market
o Cascading impact of Covid-19 on Therapeutic Obstructive Sleep Apnea Devices Market, due to the impact on its extended ecosystem
o Understanding the market behavior Pre- and Post-COVID-19 pandemic
o Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity
o We'll help you fight this crisis through our business intelligence solutions.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/39

Pre COVID-19 Analysis of Therapeutic Obstructive Sleep Apnea Devices Market -

Global market was valued at $ 4,661.6 Million in 2018 and is expected to reach of $ 9,561.3 Million by 2026, growing at a CAGR of 9.6% over the forecast period.

Obstructive sleep apnea is caused due to the blockage of the airways. This happens during sleep when the tongue folds with the soft palate and stops the air to pass on against the throat. It is being estimated that most of the mid age population tends to experience obstructive sleep apnea more than 5 times in half an hour.

Increasing number of cases in the sleep apnea is expected to drive the market for the therapeutic obstructive sleep apnea devices. It has been estimated that, around 80% of the patient who are suffering from obstructive sleep apnea are not being treated. The ratio between the total number of patients facing the obstructive sleep apnea and the patient who is being diagnosed is very minimal, so rising awareness among the patient can lead to the growth of the therapeutic obstructive sleep apnea market. Lack of awareness regarding the effects caused due to the obstructive sleep apnea such as, high blood pressure, diabetes, obesity and sometime the death of the patient may occur due to negligence and unawareness. Government initiative to raise the awareness among the people and the advanced technologies expected to give a boost to the overall obstructive sleep apnea therapeutic devices market.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/39

The main reason for dissension of therapeutic obstructive sleep apnea devices is due to the lack of acceptance from the patients, this is mainly due to the discomfort and anxiety caused by the mask. The cost of therapeutic obstructive sleep apnea devices market is very high as compared to the other sleep apnea disease. The cost is the main constraint for the increase of the therapeutic obstructive sleep apnea devices market.

Depending on the type the positive airway pressure segment held the largest market size in 2018 for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7%. Positive airways reduce the sleep apnea occurrence and protect the airways from closing. The oral application is estimated to grow at 9.5% CAGR by generating revenue by $1,768.2 million by 2026. It is expected to offer patient with greater satisfaction. Oral applications are portable, flexible and easy to use, so American Academy of Sleep Medicine (AASM) suggested to wear oral application with severe obstructive sleep apnea, who cannot wear and use positive airway pressure.

Due to the rising number of hospitals and growing investment in healthcare the hospitals and sleep laboratories segment is anticipated to drive the market over the forecast period. Hospitals and sleep laboratories segment accounted for $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

North America holds the largest market share for the therapeutic obstructive sleep apnea devices market. This region registered 10.2% CAGR and is anticipated to generate a revenue of $3,970.7 million by 2026. The Asia-Pacific is the largest growing market for the therapeutic obstructive sleep apnea devices as most of the Asian countries are not developed in the medical facilities and are unaware of the therapeutic obstructive sleep apnea devices. It is projected that the region sleep apnea devices market is expected to grow at $1,777.7 million by 2026 at a CAGR of 9.0%.

The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

About Us:
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The COVID-19 Fallout: What to Expect from Therapeutic Obstructive Sleep Apnea Devices Industry in 2020? here

News-ID: 2043382 • Views:

More Releases from Research Dive

Electronic Data Management Market Expected to Rise Progressively by 2031 Due to the Increasing Applications of Electronic Data Management in the Industrial Sector
Electronic Data Management Market Expected to Rise Progressively by 2031 Due to …
The global electronic data management market is expected to witness significant growth by 2031, owing to the rising applications of electronic data management in the industrial sector. The North America region was the most dominant in 2021. As per the report published by Research Dive, the global electronic data management market is projected to garner a revenue of $19,289.5 million and rise at a stunning CAGR of 12.2 % during
Gastric Cancer Market Predicted to Make a Strong Comeback after the Pandemic Debacle with a Stunning CAGR of 17.9% in the 2022-2031 Timeframe
Gastric Cancer Market Predicted to Make a Strong Comeback after the Pandemic Deb …
The global gastric cancer market is predicted to observe significant growth by 2031, owing to the increasing pervasiveness of gastric cancer among people worldwide. The Asia-Pacific region generated the highest market share in 2021. As per the report published by Research Dive, the global gastric cancer market is envisioned to garner a revenue of $10,737.00 million and grow at a fascinating CAGR of 17.9% over the estimated timeframe from
Off Grid Solar Market to Exhibit 12.3% CAGR and Generate $5,825.80 Million by 2031
Off Grid Solar Market to Exhibit 12.3% CAGR and Generate $5,825.80 Million by 20 …
As per the report published by Research Dive, the global off grid solar market is predicted to generate a revenue of $5,825.80 million and grow at a stunning CAGR of 12.3% during the analysis timeframe from 2022 to 2031. The global off grid solar market is predicted to witness prominent growth by 2031, owing to the increasing demand for electricity independence across the globe. The Asia-Pacific region garnered
Roofing Materials Market to Garner a Revenue of $186.7 Billion and Exhibit a 4.3% CAGR During the Forecast Period from 2022 to 2031
Roofing Materials Market to Garner a Revenue of $186.7 Billion and Exhibit a 4.3 …
As per the report published by Research Dive, the global roofing materials market is expected to register a revenue of $186.7 billion by 2031, at a CAGR of 4.3% during the forecast period 2022-2031. The global roofing materials market is expected to grow primarily due to the growing need for waterproofing roofing materials. Re-roofing sub-segment is expected to flourish immensely. The Asia-Pacific region is predicted to grow at a high

All 5 Releases


More Releases for Obstructive

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market- (By Drug Class (Bronchodilators, Combination, Corticosteroids, Phosphodiesterase), By Type (Chronic Bronchitis, Emphysema), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market
Key Influencer in the Obstructive Laryngitis Treatment Market 2025: Growing Inci …
What Is the Forecasted Market Size and Growth Rate for the Obstructive Laryngitis Treatment Market? The market size of obstructive laryngitis treatment has witnessed robust growth in the recent past. It is projected to expand from $1.95 billion in 2024 to $2.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. The acceleration in market growth during the historic period can be accredited to increasing prevalence of diseases
Chronic Obstructive Pulmonary Disease Pipeline Therapeutics Assessment Report 20 …
(Albany, United States) As per DelveInsight's assessment, globally, the Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 70+ Chronic Obstructive Pulmonary Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. To explore more information on the latest breakthroughs in the Chronic Obstructive Pulmonary Disease Pipeline treatment landscape of the report, click here @ Chronic Obstructive
Chronic Obstructive Pulmonary Disease Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Chronic Obstructive Pulmonary Disease Market was valued at USD 10.17 Billion in 2018 and is projected to reach USD 13.9 Billion by 2026, growing at a CAGR of 4.03% from 2019 to 2026. Market Overview for Chronic Obstructive Pulmonary Disease Market Chronic Obstructive Pulmonary Disease Market OverviewChronic Obstructive Pulmonary Disease (COPD) affects millions worldwide, presenting a significant healthcare burden due to its chronic nature and progressive symptoms. The market
Chronic Obstructive Pulmonary Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Chronic Obstructive Pulmonary Disease Pipeline Insight 2024" report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Chronic Obstructive Pulmonary
Obstructive Lung Disease Pharmaceutical and Healthcare Analysis Information 2023
Market Highlights The use of drugs has emerged as an effective solution for the treatment of COPD and asthma, which largely contributes to the growth of the global obstructive lung disease market. The market is driven by the growing COPD and asthmatic patient population, as well as the FDA approval for novel products and its wide acceptance. Increasing government initiatives to control COPD and asthma further, fuel the growth of this